Status:
COMPLETED
Impact of HIV on Measles and Measles Immunisation
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborating Sponsors:
Burroughs Wellcome
London School of Hygiene and Tropical Medicine
Conditions:
HIV Infection
Measles
Eligibility:
All Genders
2-15 years
Brief Summary
We conducted a longitudinal study to assess the immunogenicity of standard-titer measles vaccine in HIV-infected and uninfected Zambian children. The study hypothesis was that HIV-infected children wo...
Detailed Description
Despite great progress in measles control in sub-Saharan Africa, measles remains a significant cause of morbidity and mortality in young children. In regions of high HIV prevalence, measles virus tran...
Eligibility Criteria
Inclusion
- children aged 2 to 8 months presenting for well-child care
- reside within 10 miles of the study clinic
- parents or caretakers provide signed informed consent
Exclusion
- children with severe illness
Key Trial Info
Start Date :
May 1 2000
Trial Type :
OBSERVATIONAL
End Date :
September 1 2004
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT00247091
Start Date
May 1 2000
End Date
September 1 2004
Last Update
November 1 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chawama Clinic
Lusaka, Zambia